Citi reiterates Buy rating on Ultragenyx Pharma stock despite trial delay

Related
EU official says bloc to explore Asia pacts as U.S. tariffs ...
8 minutes ago
0
Aurora Mobile stock jumps as co evaluates Solana for cryptoc...
9 minutes ago
0
'Robust' cybersecurity growth expected in H2, with AI adding...
14 minutes ago
0
OPEC sees strong Q3 oil demand, tight market ahead as output...
21 minutes ago
0
Trump marks first anniversary of assassination attempt by jo...
22 minutes ago
0
German defense minister calls arms makers to ramp up capacit...
23 minutes ago
0
European finance ministers brace for Trump’s surprise 30% EU...
27 minutes ago
0
Central Bank of India 1111-day FD vs Union Bank of India 456...
30 minutes ago
0
Nasdaq, S&P, Dow futures slip as Trump unveils more tariffs
39 minutes ago
0
Nifty50 manages to hold 25,000 mark as market falls for 4h d...
45 minutes ago
0
Hyundai Motor expands AURA lineup, introduces S AMT variant
46 minutes ago
0
NaaS Technology announces plan to implement ADS ratio change...
51 minutes ago
0
RenGen III raises $1.75M privately
1 hour ago
0
Trending
Popular
رشیدپور ترامپ را به مصاحبه دعوت کرد!
6 days ago
5
© FBT Company 2025. All rights are reserved